With a modeling career that spans over three decades, Molly Sims clearly knows a thing or two about maintaining flawless skin. The supermodel is a huge fan of under-eye patches, and told CNN ...

City officials say a proposed desal plant near CC Polymers could help provide fresh water for both the company and the entire Coastal Bend region. Ilhan Omar's response to question about marrying ...

This post contains spoilers for this week’s episode of Alien: Earth, “Observation,” now streaming on Hulu. After Wendy and her brother Joe spent most of last week’s installment out of action, both are ...

Eddie Possehl is a dynamic and driven writer/director with a passion for the written word and all things film, television, comics, and games. His passion for storytelling led him to establish his own ...

eYe Junya Watanabe MAN and Brooks Brothers are continuing their long-standing collaborative effort with a new set of spring and summer-ready garments for SS25. The concise offering includes a blazer ...

All the Latest Game Footage and Images from Tetris the Grand Master 4: Absolute Eye The action puzzle game Tetris the Grand Master first appeared in game arcades in August 1998, and became a beloved ...

The action puzzle game Tetris the Grand Master first appeared in game arcades in August 1998, and became a beloved game for gamers as a Tetris game packed with addictive elements. Then, Tetris the ...

Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its workforce by "approximately" 20%, it ...

The Sims 4 mods enhance teen gameplay with rebellious actions, summer camps, and unique traits for more exciting experiences. Mods like Teen Lifestyle Game Pack and Full-Time Jobs Collection add depth ...

Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after sharing preliminary results for the ADC last month. The Boston biotech is ...

Pyxis Oncology (NASDAQ:PYXS) is down ~38% in after-hours trading Wednesday after posting preliminary phase 1 data on PYX-201, an antibody-drug conjugate for solid tumors. The data presented was in six ...